RGEN Q3 2021 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$178M+89.5% YoY

Gross Profit

$103M57.6% margin

Operating Income

$45M25.4% margin

Net Income

$33M18.8% margin

EPS (Diluted)

$0.58

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$12M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$526M

Stockholders' Equity

$1.7B

Cash & Equivalents

$621M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$178M	$94M	+89.5%
Gross Profit	$103M	$54M	+88.7%
Operating Income	$45M	$22M	+105.8%
Net Income	$33M	$15M	+130.2%

Revenue Segments

Product

$178M100%

Royalty

$39,0000%